Page 65 - Syndipharma

Farabi Pharmaceutical Co.

IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

Founded: 1993

HQ Office: 15 Km. of Shiraz Road, Isfahan - IRAN.
th
Plant Location: 15 Km. of Shiraz Road, Isfahan - IRAN.
th
Capital: 400 Billions Rls.

Major Shareholder: Tamin Pharmaceutical Investment Company (TPICO)

Employees: 470

Company Profile:
Farabi Pharmaceutical Company which was inaugurated in January 1993 for the mass production of antibiotics is the
leading pharmaceutical company in the region.
The Complex enjoys a wealthy ten acre work space site built in a forty hectare stretch of land, itself advantageously
placed on the higher grounds adjacent to the southern mountains of Isfahan.
The Complex produces various oral antibiotic-related and non-antibiotic products and dietary supplements which
sets the prestigious annual production record of1,200,000,000 capsules45,000,000 suspensions and 460,000,000
film-coated tablets .To guarantee the required clinical effect for its products, Farabi acquires its raw materials from
the most renowned and reliable international producers. All production procedures are managed According to the
cGMP guidelines, FDA and WHO, with the most up to date production machinery and equipment right from gran-
ulation down to packing and cartoning, based on the international standards EP, BP, USP. Furthermore Managerial
regulatories such as:
Quality Management “ISO 9001:2008 “, Environment Management “ISO 14001:2004 “ and Occupational Health Sys-
tem & Safety” OHSAS 18001:2007 “have been stabilized at farabi by the MIC institute of England.. Also stabilized
laboratory management “ISO 17025:2008” by the NACI center.

Production Lines:
Since all pharmaceutical products aim at health recovery, three factors must be highlighted as crucial watch points
during the manufacturing process: safety, bioavailability and stability.
To secure international standards in a pharmaceutical product, it is inevitable that the formulation, mixing, batch
preparation, filling and packaging of all products be done automatically with no dependence on manual handling.
Adopting the cGMP guidelines and watching the often-made managerial quote “BOX IN A BOX”, each Farabi manu-
facturing process has its own special space and corresponding production line. In this way, products are
protected against any contamination which might occur as the result of a shared interior manufacturing space. Dif-
ferent sections thus defined and specified are equipped with their own air-filtering systems. Advanced machinery
facilitates the automatic handling of raw materials through the subsequent processes of formulation, mixing, batch
preparation, filling and packaging. Another highlight of Farabi’s technological competence is its capability to convert
fine powder to compact powder. As we know, it is an advantage for providing the medical powder with good distri-
bution of particle size, good flow and higher chemical and physical stability.
This method is very useful and profitable for those compounds that are not stable in humidity or those compounds
that are susceptible to hydrolysis.
Finally, Farabi Pharmaceutical Complex has been designed for the 21st century.
FARABI EXISTS TO PROMOTE THE WELL-BEING OF SOCIETY.

Target Countries for Exports:
Iraq, Afghanistan, Somali, Belarus, Kazakhstan, Tanzania, Tajikistan, Cameron, Sri Lanka, Kyrgyzstan, Uganda, Emir-
ates, Yemen, Azerbaijan

64